Search

Author/Creator Mack, M.

1. AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial. (23rd January 2014)

Authors:
Westhovens, R.; Bingham, C. O.; Weinblatt, M.; Fleischmann, R.; Keystone, E.; Hsia, E. C.; Hsu, B.; Kim, L.; Mudivarthy, S.; Mack, M.; Goldstein, N.; Braun, J.; Kavanaugh, A.; Mendelsohn, A.; Kay, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A873
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AB0491 Fatigue is an independent variable predicting physical function and DAS-28 remission for patients with rheumatoid arthritis treated with intravenously administered golimumab: results from phase 3, placebo controlled clinical trial. (23rd January 2014)

Authors:
Westhovens, R.; Weinblatt, M.E.; Han, C.; Gathany, T.; Kim, L.; Mack, M.; Lu, J.; Baker, D.; Mendelsohn, A.M.; Bingham, C.O.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
665
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development. Issue 9 (28th March 2016)

Authors:
Schiechl, G.; Hermann, F. J.; Rodriguez Gomez, M.; Kutzi, S.; Schmidbauer, K.; Talke, Y.; Neumayer, S.; Goebel, N.; Renner, K.; Brühl, H.; Karasuyama, H.; Obata‐Ninomiya, K.; Utpatel, K.; Evert, M.; Hirt, S. W.; Geissler, E. K.; Fichtner‐Feigl, S.; Mack, M.
Journal:
American journal of transplantation
Issue:
Volume 16:Issue 9(2016:Sep.)
Page Start:
2574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FRI0169 Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with results observed by 2 weeks: Results of the phase 3, multicenter, double-blind, placebo-controlled trial. (23rd January 2014)

Authors:
Weinblatt, M.E.; Bingham, C.O.; Mendelsohn, A.M.; Kim, L.; Mack, M.; Lu, J.; Baker, D.; Westhovens, R.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
368
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. FRI0266 Health-Related Quality of Life of Patients with Rheumatoid Arthritis Achieving DAS28 Remission, Improvement in Physical Function and NO Radiographic Progression after Treatment with Intravenous Golimumab. (10th June 2014)

Authors:
Westhovens, R.; Weinblatt, M.E.; Han, C.; Kim, L.; Mack, M.; Lu, J.; Baker, D.; Mendelsohn, A.; Bingham, C.O.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
479
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Generation of an equine biobank to be used for Functional Annotation of Animal Genomes project. (11th October 2018)

Authors:
Burns, E. N.; Bordbari, M. H.; Mienaltowski, M. J.; Affolter, V. K.; Barro, M. V.; Gianino, F.; Gianino, G.; Giulotto, E.; Kalbfleisch, T. S.; Katzman, S. A.; Lassaline, M.; Leeb, T.; Mack, M.; Müller, E. J.; MacLeod, J. N.; Ming‐Whitfield, B.; Alanis, C. R.; Raudsepp, T.; Scott, E.; Vig, S.
Journal:
Animal genetics
Issue:
Volume 49:Number 6(2018)
Page Start:
564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Inhibition of Innate Co‐Receptor TREM‐1 Signaling Reduces CD4+ T Cell Activation and Prolongs Cardiac Allograft Survival. Issue 5 (6th March 2013)

Authors:
Schiechl, G.; Brunner, S. M.; Kesselring, R.; Martin, M.; Ruemmele, P.; Mack, M.; Hirt, S. W.; Schlitt, H. J.; Geissler, E. K.; Fichtner‐Feigl, S.
Journal:
American journal of transplantation
Issue:
Volume 13:Issue 5(2013:May)
Page Start:
1168
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. OP0170 Achieving ASDAS-CRP major improvement and inactive disease in patients with ankylosing spondylitis after treatment with golimumab is associated with normalized health related quality of life: Two-year results from the go-raise trial. (23rd January 2014)

Authors:
van der Heijde, D.; Deodhar, A.; Braun, J.; Mack, M.; Hsu, B.; Gathany, T.; Han, C.; Inman, R.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
112
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗